Rait, Antonina S <br/><br/>
Tumor-targeting, systemically delivered antisense HER-2 chemosensitizes human breast cancer xenografts irrespective of HER-2 levels.  [electronic resource] 

 -  Molecular medicine (Cambridge, Mass.)  Aug 2002 
 - 475-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1076-1551 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Docetaxel<br/>Female<br/>Folic Acid--metabolism<br/>Genes, erbB-2<br/>Genetic Therapy<br/>Genetic Vectors<br/>Humans<br/>Liposomes<br/>Mammary Neoplasms, Experimental--genetics<br/>Mice<br/>Oligonucleotides, Antisense<br/>Paclitaxel--analogs & derivatives<br/>Taxoids